Author

Alessandro Gronchi

Fondazione IRCCS Istituto Nazionale dei TumoriORCID 0000-0002-4703-3534Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Sandro PasqualiiD· 3 shared Paola ColliniiD· 2 shared Paul H. HuangiD· 2 shared Rosalba MiceliiD· 2 shared Stefano PercioiD· 2 shared Alex KentsisiD· 1 shared Amani ArthuriD· 1 shared Andrew D. JenksiD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Sandro PasqualiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 4, 2026

Histone deacetylase activity limits the response to EZH2 inhibition-based therapy in epithelioid sarcoma and is targetable by epigenetic combination

Noemi Arrighetti, Cesare Soffientini, Valentina Zuco…·Sandro Pasquali

This paper identifies HDAC inhibition as a strategy to overcome resistance to EZH2 inhibitors in INI1-deficient epithelioid sarcoma by restoring H3K27 acetylation and enhancing therapeutic response.

1 citation

humanChIP-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintApr 20, 2026

Active Surveillance Reveals a Systemic Pro-Resolving Th2 Immune Program Linked to 1 Desmoid Tumor Regression

Laura Bergamaschi, Stefano Percio, Yiyi Zhu…·Chiara Colombo

This study identifies a Th2 immune program linked to desmoid tumor regression through active surveillance and multi-omics analysis.

DOI 10.64898/2026.04.16.718860

humanflow cytometry

𝕏 PostBluesky

Cancer BiologyCancer MedicinePeer-reviewedJul 1, 2024

Proteomic characterisation of Sarculator nomogram-defined risk groups in soft tissue sarcomas of the extremities and trunk wall

Madhumeeta Chadha, Sara Iadecola, Andrew D. Jenks…·Paul H. Huang

This study identifies a DNA replication protein signature (SPM6) that improves risk stratification in soft tissue sarcomas when combined with the Sarculator nomogram.

4 citations

humanproteomics

𝕏 PostBluesky